Product
Sm-p80 + GLA-SE
2 clinical trials
1 indication
Indication
SchistosomiasisClinical trial
A Phase 1, Open-Label, Dose-Escalation Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy AdultsStatus: Completed, Estimated PCD: 2024-03-19
Clinical trial
A Phase 1b, Multicenter, Randomized, Placebo-controlled, Observer-blinded, Dose-escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and MadagascarStatus: Recruiting, Estimated PCD: 2024-12-01